Cure My Disease

Don't miss your cure!

 Log in / Sign up

When cancer blocks the airway, doctors lack a playbook. experts aim to write one.

NCT ID NCT07822815

Knowledge-focused Sponsor: Onco Critical Care Society Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Tumours in the head, neck, or chest can narrow or distort the airway, and standard difficult-airway guidelines offer little cancer-specific advice. This study asks an international panel of anaesthesiologists, intensive care doctors, lung specialists, head and neck surgeons, and emergency physicians to rate candidate statements on how to predict, prepare for, and manage these cases. Panellists vote anonymously in at least three rounds, seeing group results between rounds, until statements reach defined agreement thresholds. The goal is a consensus statement that fills a gap in current guidance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
expert consensus questionnaires
What this could lead to
If the panel reaches agreement, the statement could give doctors a shared, cancer-specific playbook for predicting and handling airway problems that general guidelines miss.
What could go wrong
Consensus statements reflect expert opinion, not tested patient outcomes, and the panel may fail to agree on key points, leaving those questions unanswered.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Practicing clinicians with recognized expertise in airway management in patients with cancer, drawn from anesthesiology, intensive care medicine, interventional pulmonology, head and neck surgery, and emergency medicine. Panellists are identified from author lists of relevant publications and from professional society membership and faculty lists, and are selected to represent multiple World Health Organization regions and both high-income and low- or middle-income health systems. No patients are enrolled and no patient-identifiable data are collected.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Substantial current clinical practice involving airway management in patients with cancer, in anaesthesiology, intensive care medicine, interventional pulmonology, head and neck surgery, or emergency medicine At least five years of independent practice following completion of specialist training Demonstrated scholarly contribution to the field, evidenced by peer-reviewed publication, invited lecturing, or a leadership role in a relevant professional society or guideline-development body Willingness to complete all planned Delphi rounds and to review the final manuscript Sufficient written English to complete the survey instrument without translation Membership of the study Steering Committee, whose members do not vote in any round Fewer than five years of independent practice following specialist training No current clinical practice involving airway management in patients with cancer Participation as a pilot tester of the Round 1 instrument, whose responses are excluded from all consensus calculations Exclusion Criteria: \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Airway management are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck neoplasm Head and Neck Neoplasms mediastinal cancer neoplasm neoplasm of mediastinum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Airway management Airway obstruction upper Head and neck neoplasms Intubation, intratracheal Mediastinal neoplasms Neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Max Super specialty Hospital Shalimar bagh

    Delhi, National Capital Territory of Delhi, 110085, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.